214 related articles for article (PubMed ID: 1702815)
21. Interleukin 2 receptors are expressed by alveolar macrophages during pulmonary sarcoidosis and are inducible by lymphokine treatment of normal human lung macrophages, blood monocytes, and monocyte cell lines.
Hancock WW; Muller WA; Cotran RS
J Immunol; 1987 Jan; 138(1):185-91. PubMed ID: 3097144
[TBL] [Abstract][Full Text] [Related]
22. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
[TBL] [Abstract][Full Text] [Related]
23. Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin.
Brandenburg K; Jürgens G; Müller M; Fukuoka S; Koch MH
Biol Chem; 2001 Aug; 382(8):1215-25. PubMed ID: 11592403
[TBL] [Abstract][Full Text] [Related]
24. Bacterial lipopolysaccharide, phorbol myristate acetate, and muramyl dipeptide stimulate the expression of a human monocyte surface antigen, Mo3e.
Todd RF; Alvarez PA; Brott DA; Liu DY
J Immunol; 1985 Dec; 135(6):3869-77. PubMed ID: 3934269
[TBL] [Abstract][Full Text] [Related]
25. Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor-alpha.
van Lenten BJ; Fogelman AM
J Immunol; 1992 Jan; 148(1):112-6. PubMed ID: 1727858
[TBL] [Abstract][Full Text] [Related]
26. Lactoferrin activates macrophages via TLR4-dependent and -independent signaling pathways.
Curran CS; Demick KP; Mansfield JM
Cell Immunol; 2006 Jul; 242(1):23-30. PubMed ID: 17034774
[TBL] [Abstract][Full Text] [Related]
27. Activities derived from established human myeloid cell lines reverse the suppression of cell line colony formation by lactoferrin and transferrin.
Broxmeyer HE; Rubin BY; Berman E; Juliano L; Lu L; Hast LJ; Cooper S; Singer JW
Exp Hematol; 1986 Jan; 14(1):51-9. PubMed ID: 3455916
[TBL] [Abstract][Full Text] [Related]
28. Binding sites for endotoxins (lipopolysaccharides) on human monocytes.
Couturier C; Haeffner-Cavaillon N; Caroff M; Kazatchkine MD
J Immunol; 1991 Sep; 147(6):1899-904. PubMed ID: 1716284
[TBL] [Abstract][Full Text] [Related]
29. Functional activities of acidic isoferritins and lactoferrin in vitro and in vivo.
Broxmeyer HE; Gentile P; Cooper S; Lu L; Juliano L; Piacibello W; Meyers PA; Cavanna F
Blood Cells; 1984; 10(2-3):397-426. PubMed ID: 6543656
[TBL] [Abstract][Full Text] [Related]
30. Effect of 1,25-dihydroxyvitamin D3 on induction of scavenger receptor and differentiation of 12-O-tetradecanoylphorbol-13-acetate-treated THP-1 human monocyte like cells.
Suematsu Y; Nishizawa Y; Shioi A; Hino M; Tahara H; Inaba M; Morii H; Otani S
J Cell Physiol; 1995 Dec; 165(3):547-55. PubMed ID: 7593234
[TBL] [Abstract][Full Text] [Related]
31. Expression and release of the monocyte lipopolysaccharide receptor antigen CD14 are suppressed by glucocorticoids in vivo and in vitro.
Nockher WA; Scherberich JE
J Immunol; 1997 Feb; 158(3):1345-52. PubMed ID: 9013978
[TBL] [Abstract][Full Text] [Related]
32. Granulocyte-macrophage colony-stimulating factor, but not macrophage colony-stimulating factor, suppresses basal and lipopolysaccharide-stimulated complement factor production in human monocytes.
Høgåsen AK; Hestdal K; Abrahamsen TG
J Immunol; 1993 Sep; 151(6):3215-24. PubMed ID: 7690797
[TBL] [Abstract][Full Text] [Related]
33. Blockade of Fc receptor-mediated binding to U-937 cells by murine monoclonal antibodies directed against a variety of surface antigens.
Kurlander RJ
J Immunol; 1983 Jul; 131(1):140-7. PubMed ID: 6223069
[TBL] [Abstract][Full Text] [Related]
34. CD14 and tolerance to lipopolysaccharide: biochemical and functional analysis.
Labeta MO; Durieux JJ; Spagnoli G; Fernandez N; Wijdenes J; Herrmann R
Immunology; 1993 Nov; 80(3):415-23. PubMed ID: 7507090
[TBL] [Abstract][Full Text] [Related]
35. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein.
Leeuwenberg JF; Dentener MA; Buurman WA
J Immunol; 1994 May; 152(10):5070-6. PubMed ID: 7513728
[TBL] [Abstract][Full Text] [Related]
36. Pivotal advance: vasoactive intestinal peptide inhibits up-regulation of human monocyte TLR2 and TLR4 by LPS and differentiation of monocytes to macrophages.
Foster N; Lea SR; Preshaw PM; Taylor JJ
J Leukoc Biol; 2007 Apr; 81(4):893-903. PubMed ID: 16973891
[TBL] [Abstract][Full Text] [Related]
37. Lipopolysaccharide (LPS) binding in subpopulations of mouse peritoneal macrophages.
Kriegsmann J; Bräuer R
Cell Mol Biol (Noisy-le-grand); 1993 Nov; 39(7):783-9. PubMed ID: 7505675
[TBL] [Abstract][Full Text] [Related]
38. Changes in the expression of MCP-1 receptors on monocytic THP-1 cells following differentiation to macrophages with phorbol myristate acetate.
Denholm EM; Stankus GP
Cytokine; 1995 Jul; 7(5):436-40. PubMed ID: 7578981
[TBL] [Abstract][Full Text] [Related]
39. Role of phorbol ester receptors in the 12-0-tetradecanoyl-phorbol-13-acetate (TPA)-induced down-regulation of colony-stimulating factor (CSF-1) binding to murine peritoneal exudate macrophages.
Chen BD; Wilkins KL
J Cell Physiol; 1985 Aug; 124(2):305-12. PubMed ID: 3876342
[TBL] [Abstract][Full Text] [Related]
40. Modulation of cell surface antigens induced by 12-O-tetradecanoyl-phorbol 13-acetate in two myeloblastic cell lines, a promyelocytic cell line, and a monoblastic cell line: detection with five monoclonal antibodies.
Sugimoto T; Tatsumi E; Takeda K; Minato K; Sagawa K; Minowada J
J Natl Cancer Inst; 1984 Apr; 72(4):923-8. PubMed ID: 6368942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
